RENAISSANCERE HOLDINGS LTD — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that RENAISSANCERE HOLDINGS LTD filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $12.85B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $11.70B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $9.13B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $5.06B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $5.28B | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $1.40B | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $1.33B | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $1.55B | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | $896.26M | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $1.11B | Feb 5, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.68B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.87B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $2.56B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | ($1.06B) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | ($40.16M) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | $197.10M | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | $55.09M | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | $583.13M | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | ($72.92M) | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | $42.96M | Feb 5, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.69B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $4.16B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $1.91B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $1.60B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.23B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.99B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $2.14B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $1.22B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $1.03B | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $484.77M | Feb 7, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $53.80B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $50.71B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $49.01B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $36.55B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $33.96B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $30.82B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $26.33B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $18.68B | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $15.23B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $12.35B | Feb 9, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $34.59B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $33.16B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $33.45B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $26.69B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $23.78B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $19.87B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $17.29B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $11.58B | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $9.54B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $6.31B | Feb 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $11.61B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $10.57B | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $9.45B | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $5.33B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $6.62B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $7.56B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $5.97B | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $5.05B | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $4.39B | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $4.87B | Feb 7, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.83B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $8.28B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $6.52B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $4.07B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $5.23B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $5.37B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $4.71B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $4.06B | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $3.91B | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $4.21B | Feb 9, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.73B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.68B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.88B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.19B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.86B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $1.74B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $1.38B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $1.11B | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $1.36B | Feb 7, 2019 |
| FY2018 | Dec 31, 2016 | $421.16M | Feb 7, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $1.89B | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | $1.96B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $1.17B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $1.17B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $1.14B | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | $1.38B | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | $991.13M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | $989.62M | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | $948.66M | Feb 9, 2018 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 35 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 52 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (25) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 3 | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | 12 | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | (1) | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 5, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56 | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 35 | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | 52 | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | (25) | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 21, 2024 |
| FY2020 | Dec 31, 2020 | 3 | Feb 5, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 5, 2021 |
| FY2020 | Jun 30, 2020 | 12 | Feb 5, 2021 |
| FY2020 | Mar 31, 2020 | (1) | Feb 5, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 5, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 43.96M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | 50.18M | Feb 11, 2026 |
| FY2024 | Dec 31, 2023 | 52.69M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 43.72M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 44.44M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 50.81M | Feb 4, 2022 |
| FY2020 | Dec 31, 2019 | 44.15M | Feb 5, 2021 |
| FY2019 | Dec 31, 2018 | 42.21M | Feb 7, 2020 |
| FY2018 | Dec 31, 2017 | 40.02M | Feb 7, 2019 |
| FY2017 | Dec 31, 2016 | 41.19M | Feb 9, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $74.84M | Feb 11, 2026 |
| FY2025 | Dec 31, 2024 | $80.85M | Feb 11, 2026 |
| FY2025 | Dec 31, 2023 | $75.11M | Feb 11, 2026 |
| FY2024 | Dec 31, 2022 | $64.68M | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $67.83M | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $68.49M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $59.37M | Feb 4, 2022 |
| FY2020 | Dec 31, 2018 | $52.84M | Feb 5, 2021 |
| FY2019 | Dec 31, 2017 | $51.37M | Feb 7, 2020 |
| FY2018 | Dec 31, 2016 | $51.58M | Feb 7, 2019 |